Abbott Laboratories Aktie

115,58USD -0,37USD -0,32%
Abbott Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 850103 / ISIN: US0028241000
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,34
Vanguard Group, Inc. (Subfiler) 9,21
The Vanguard Group, Inc. 8,99
State Street Corp. 4,41
Capital Research & Management Co. (International Investors) 3,78
Vanguard Total Stock Market ETF 3,16
Capital Research & Management Co. (Global Investors) 3,06
BlackRock Fund Advisors 2,82
Vanguard 500 Index Fund 2,65
BlackRock Institutional Trust Co. NA 2,14
Geode Capital Management LLC 2,01
Wellington Management Co. LLP (Wellington Breakout) 1,44
Fidelity 500 Index Fund 1,23
Norges Bank (13F) 1,17
JPMorgan Investment Management, Inc. 1,15

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 107 000 109 000 113 000 115 000 114 000
Umsatz pro Mitarbeiter in Mio. EUR 0,30 0,32 0,38 0,38 0,35

Bilanz (in Mio. USD) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 15 667 20 441 24 239 25 224 22 670
Summe Anlagevermögen 52 220 52 107 50 957 49 214 50 544
Summe Aktiva 67 887 72 548 75 196 74 438 73 214

Bilanz (in Mio. USD) - Passiva

2019 2020 2021 2022 2023
Summe Fremdkapital 36 586 39 545 39 172 37 533 34 387
Summe Eigenkapital 31 301 33 003 36 024 36 905 38 827
Summe Passiva 67 887 72 548 75 196 74 438 73 214

Adresse

100 Abbott Park Road, 60064-6400 Abbott Park
Telefon +1 (224) 667-6100
Internet http://www.abbott.com

Management

Alison Davies
Treasurer & Vice President
Andrea F. Wainer
Executive VP-Rapid & Molecular Diagnostics
Claire L. Babineaux-Fontenot
Independent Director
Daniel Gesua Sive Salvadori
Executive Vice President-Nutritional Products
Daniel J. Starks
Independent Director
Darren W. McDew
Independent Director
Gene Huang
Chief Economist & Vice President
Hubert L. Allen
Secretary, Executive VP & General Counsel
Jim Leffelman
Manager-Expense Reporting
Joanne T. Beck
Global Pharmaceutical Operations
John A. McCoy
Vice President-Finance & Controller
John G. Stratton
Independent Director
John M. Capek
Executive Vice President-Ventures
Karen Wong Chayavirabood
Regional Director-Asia
Kathryn S. Collins
Vice President-Commercial Legal Operations
Lisa D. Earnhardt
Group President-Medical Devices & Executive VP
Mary K. Moreland
Executive Vice President-Human Resources
Melissa Brotz
Chief Marketing & Communications Officer
Michael F. Roman
Independent Director
Michael G. O'Grady
Independent Director
Michelle A. Kumbier
Independent Director
Nancy McKinstry
Independent Director
Paola Gonzalez
Independent Director
Philip P. Boudreau
Chief Financial Officer & Senior VP-Finance
Randel William Woodgrift
Senior Vice President-Cardiac Rhythm Management
Robert B. Ford
Chairman, President & Chief Executive Officer
Robert J. Alpern
Independent Director
Sally E. Blount
Independent Director
Scott J. House
Senior VP-Regulatory & Engineering Services
Scott Leinenweber
Senior Vice President-Licensing & Acquisitions